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Summary
Bacillus thuringiensis (Bt) is a soil bacterium that forms spores during the stationary
phase of its growth cycle. The spores contain crystals, predominantly comprising one
or more Cry and ⁄or Cyt proteins (also known as d-endotoxins) that have potent and
specific insecticidal activity. Different strains of Bt produce different types of toxin,
each of which affects a narrow taxonomic group of insects. Therefore, Bt toxins
have been used as topical pesticides to protect crops, and more recently the proteins
have been expressed in transgenic plants to confer inherent pest resistance. Bt trans-
genic crops have been overwhelmingly successful and beneficial, leading to higher
yields and reducing the use of chemical pesticides and fossil fuels. However, their
deployment has attracted some criticism particularly with regard to the potential
evolution of pest-resistant insect strains. Here, we review recent progress in the
development of Bt technology and the countermeasures that have been introduced
to prevent the evolution of resistant insect populations.
Introduction
The insecticidal properties of Bt were recognized many
years before the bacterium was identified, with some
accounts suggesting that Bt spores may have already been
in use in ancient Egypt. In the modern era, the bacterium
was isolated in 1901 by the Japanese biologist Shigetane
Ishiwatari during an investigation into wilt disease in silk
worms, and he named it Bacillus sotto. Ten years later, the
same bacterium was isolated by Ernst Berliner from a dis-
eased Mediterranean flour moth (Ephestia kuehniella) in
the German province of Thuringia, and it was named Bacil-
lus thuringiensis (Siegel, 2000). The defining feature of Bt is
its ability to produce proteinaceous crystals during sporula-
tion. Bt is a member of the Bacillus cereus group of Gram-
positive, spore-forming soil bacteria, and occasionally the
bacteria lose their ability to form crystals and then become
indistinguishable from B. cereus itself. Similarly, B. cereus
can be transformed into Bt, and investigations into the
transformation mechanism led to the discovery that crystal
formation is conferred by genes carried on a plasmid. The
genes, which encode Cry ⁄Cyt proteins, become active dur-
ing sporulation because they are controlled by a dedicated
RNA polymerase that is also synthesized specifically while
spores are forming. Up to 20% of the spore protein con-
tent is represented by these Cry ⁄Cyt toxins (Aronson,
2002).
The insecticidal properties of the crystals were discov-
ered when dead flour moth caterpillars were found to be
loaded with spores and crystals. Direct contact between
the spores ⁄ crystals and healthy caterpillars had no effect,
but when the spores and crystals were coated onto leaves,
the caterpillars stopped feeding and died. After recogniz-
ing the potential of Bt as an insecticide, Mattes (1927) iso-
lated the Bt strain discovered by Ernst and subsequent
field trials against the European corn borer (Ostrinia
nubilalis) gave promising results (Husz, 1930). This work
eventually led to the development of Sporeine, a commer-
cial Bt insecticide, which was used for the first time in
1938.
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The biology of Bt toxins
Sporeine targeted lepidopteran insects, and the active
ingredient was initially thought to be a food-borne inva-
sive pathogen. However, this theory was discarded when
direct injection of crystals into caterpillars was shown to
have no effect. Careful time-course analysis of the guts of
caterpillars feeding on contaminated food revealed the
disruption of cilia on the brush border of midgut epithelial
cells shortly after ingestion of the crystals, followed by cell
swelling and lysis. The gut contents (including bacterial
spores) were thus released into the body cavity, allowing
bacteria to breed. Once the supply of nutrients was
exhausted, the bacteria formed spores that could spread
to a new host feeding on either the cadaver or the con-
taminated vegetation.
These early experiments showed that Bt toxins needed
to be activated in the gut, and it was soon discovered that
the critical factors were an alkaline environment and the
presence of specific proteases, which cleaved the innocu-
ous pro-toxin into its active form. Once activated by prote-
olysis, each toxin binds to receptors in the brush border
membrane and causes pores to open, disrupting the
movement of solutes across the gut epithelium and caus-
ing the influx of water. The toxins were shown to be orally
lethal to caterpillars in pure form, and the pro-toxins could
be converted into active toxins in vitro, using specific pro-
teases under alkaline conditions. The requirement for alka-
line conditions, specific proteases and specific receptors
explains why Bt is harmless to mammals (which have an
acidic gut and lack the corresponding receptors) and why
each toxin has a narrow host range.
Toxin structure and specificity
Many researchers have attempted to introduce taxonomic
classification systems for Bt, using various criteria such as
serotyping, phage susceptibility and plasmid profiles, and
this has resulted in the classification of approximately 100
subspecies. Although there is a good correlation between
Bt subspecies and insect host range at the family level, the
relationship tends to break down at the genus and species
levels because most Bt strains can synthesize more than
one toxin, resulting in complex and overlapping host pro-
files. For example, most Bt kurstaki strains are specific for
lepidopteran insects (butterflies and moths), whereas isra-
elensis strains are specific for dipterans (flies) and morri-
soni strains are specific for coleopterans (beetles). Other
strains are not active against insects at all, but are toxic
towards different invertebrates. For example, Bt strains
containing only Cry5- and Cry6-type toxins are active
against nematodes.
At the genus and species level, it is more useful to clas-
sify Bt strains functionally on the basis of which toxin pro-
teins they produce, as this is a more logical way to define
the host range. The toxins can be described in terms of
their amino acid sequences, protein structures and modes
of activity (Crickmore et al., 1998). Cry toxins interact with
specific receptors located on the surface of midgut epithe-
lial cells and are activated by host proteases following
receptor binding, resulting in the formation of a pre-pore
oligomeric structure that is insertion competent. In con-
trast, Cyt toxins directly interact with membrane lipids and
insert into the membrane. The known Cry and Cyt pro-
teins now fall into 32 sets including Cyt1, Cyt2 and Cry1
to Cry67 (Crickmore et al., 2010; Figure 1).
Despite their sequence diversity, all Cry proteins share
a similar overall tertiary structure, as exemplified by the
six structures solved thus far by X-ray crystallography
(Cry1Aa, Cry2Aa, Cry3Aa, Cry3Bb, Cry4Aa and Cry4Ba)
(Figure 2). The C-terminal portion is involved in crystal
formation but is not part of the mature toxin, as it is
cleaved off in the insect gut. The N-terminal portion is
the toxin itself, and it comprises three domains. Domain I
is a bundle of seven a-helices, six of which are amphi-
pathic encircling the seventh hydrophobic helix, and this
domain is responsible for membrane insertion and pore
formation. Domain II consists of three anti-parallel
b-sheets with exposed loop regions, and domain III is a
b-sandwich. Both domains confer receptor binding speci-
ficity thus helping to define the host range (Boonserm
et al., 2006).
A current model suggests that domains II and III initially
bind to primary receptors (cadherins) which cleave the
toxin within domain I and induce oligomerization, which
in turn promotes binding to high-affinity secondary recep-
tors tethered to the membrane via C-terminal glycosyl-
phosphatidylinositol anchors (Sobero´n et al., 2009). The
requirement for oligomerization has recently been con-
firmed through the isolation of dominant-negative muta-
tions of Cry1Ab (Rodrı´guez-Almaza´n et al., 2009). An
alternative model (Zhang et al., 2006) suggests that initial
binding triggers a Mg2+-dependent signalling cascade that
causes G-protein dependent cAMP accumulation and the
activation of protein kinase A. Phylogenetic analysis has
established that the diversity of the Cry family evolved by
the independent evolution of the three domains and by
swapping of domain III among toxins.
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Figure 1 Phylogenetic trees representing (a) three-domain Cry proteins, and (b) related proteins (Cyt, Bin and Mtx).
Source: http://www.lifesci.sussex.ac.uk/home/Neil_Crickmore/Bt/. The phylogenetic trees are modified from a TREEVIEW visualization of NEIGHBOR treat-
ment of a CLUSTALW multiple alignment and distance matrix of the full-length toxin sequences, as described by Crickmore et al. (2010). The grey
vertical bars demarcate the four nomenclature ranks.
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Development of Bt topical pesticides
Although Sporeine was used from 1938 in France, it was
not registered as a pesticide in the United States until
1961. By this time, other Bt products such as Thuricide
were already on the market, most based on kurstaki strain
HD1 and active against lepidopteran pests (Baum et al.,
1999). Despite their beneficial properties, these early Bt
products did not compete well against chemical pesticides
because of their poor performance. Commercial activities
concentrated on two strategies to overcome these chal-
lenges, namely process development to increase the effi-
ciency of the Bt products, and strain improvement to
increase the intrinsic toxicity of the bacteria.
Process development began with improved fermentation
and harvesting procedures, but perhaps the most impor-
tant aspect was formulation. Liquid suspensions were the
most convenient to handle, but tended to deteriorate in
storage, while powders were easier to store and transport
but drying was expensive and reformulation more compli-
cated for the end user. These challenges were addressed
by the addition of excipients such as suspension agents to
prevent suspensions settling and preservatives to increase
shelf life, and in the case of powders by adding chemicals
to improve pouring and wetting. UV screening agents
were also used, to prevent rapid photolysis after spraying
(Burges and Jones, 1998a). These improvements, in addi-
tion to more rigorous quality control and the standardiza-
Figure 1 Continued
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tion of potency testing, led to a sixfold or more increase
in efficacy in the field (Burges and Jones, 1998b).
Strain improvement in the 1960s led to the replacement
of many of the early products with new Bt strains that
were up to 10-fold more potent than their predecessors,
and the search for new and better strains continues to this
day. Most Bt products are derived from kurstaki HD1 (e.g.
Biobit, Dipel and Thuricide) although other strains are
used to tackle lepidopteran pests (kurstaki SA-11, kurstaki
SA-12), diptera (israeliensis) and coleoptera (tenebrionis)
(Kaur, 2000). A selection of Bt topical pesticides is listed in
Table 1.
Strain search and assessment programs initially involved
bioassays and biochemical testing, but this has been
replaced by PCR testing for specific toxin signatures. This
can determine whether increased potency is achieved by
higher toxin expression levels or the presence of a novel
toxin, the latter offering the prospect of controlling differ-
ent ranges of pests (Kuo and Chak, 1996; Porcar and
Jua´rez-Pe´rez, 2003). Tailoring the host range can be
achieved not only through the discovery of new toxins,
but also by creating new bacterial strains carrying
previously unknown combinations of existing toxins, a pro-
cess that can be implemented by conjugation or direct
transformation (Gonza´lez et al., 1982; Kronstad et al.,
1983; Carlton and Gonzalez, 1985) (Table 2). Examples of
combination pesticides produced by conjugation include
Table 1 Bt topical products based on natural strains (Kaur et al.,
2000). Bt kurstaki HD-12 has been renamed SA-11
Trade name Subspecies and strain Target insect
Biobit Bt kurstaki HD-1 Lepidoptera
Dipel Bt kurstaki HD-1 Lepidoptera
Florbac Bt aizawai Lepidoptera
Costar Bt kurstaki SA-12 Lepidoptera
Delfin Bt kurstaki SA-11 Lepidoptera
Thuricide Bt kurstaki HD-1 Lepidoptera
Tekar Bt israeliensis Diptera
Javelin Bt kurstaki SA-11 Lepidoptera
Bactimos Bt israliensis Diptera
Vectolex GC Bacillus sphaericus Diptera
Bactospeine Bt kurstaki HD-1 Lepidoptera
Acrobe Bt israliensis Diptera
Novodor Bt tenebrionis Coleoptera
Trident Bt tenebrionis Coleoptera
Figure 2 Structure of three-domain Cry proteins. (a) Primary structure, showing domain organization of representative members of each Cry
family. (b) Conserved tertiary structure, showing the positions of the three domains. Source: de Maagd et al. (2001).
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Foil, a product based on strain EG2424, which produces
Cry1Ac from Bt kurstaki (active against the European corn
borer), and Cry3A from Bt tenebrionis (active against the
Colorado potato beetle, Leptinotarsa decemlineata) (Carl-
ton and Gawron-Burke, 1993). Strain EG2348 (created by
Ecogen) synthesizes a combination of Cry proteins particu-
larly active against specific lepidopteran pests that infest
soybean crops, and this is the active ingredient of Condor.
It is not always possible to introduce plasmids by conjuga-
tion, particularly if this results in the coexistence of two
plasmids with similar origins of replication in the same cell,
as they would be incompatible. In such cases, the relevant
genes can be inserted onto a different plasmid in Escheri-
chia coli using standard cloning methods and that plasmid
can be introduced into an existing Bt strain by artificial
transformation (Arantes and Lereclus, 1991). Today, the Bt
biopesticide market is dominated by Abbott Laboratories
(Chicago, IL) (since the acquisition in 1995 of Novo-
Nordisk’s biopesticide business) and Novartis (created
through the merger in 1996 of Ciba and Sandoz), together
accounting for >70% of global production. The other 30%
is divided among approximately 30 companies with over
100 different Bt product formulations, most containing a
single Bt toxin but some combining up to five.
Advantages and disadvantages of topical Bt
pesticides
Topical Bt sprays are advantageous in terms of their
safety, specificity and potency compared to chemical
sprays, and are also biodegradable, which provides for a
large and competitive market (Table 3). However, this last
‘advantage’ needs to be cited with caution, because Bt is
only effective when present on the plant organs on which
insects feed. Usually Bt is applied when early instar larvae
are present, because older larvae are more tolerant. Bt
sprays persist for only a few days on the leaf surface
because UV light, weather, the chemical environment of
the leaf surface and the presence of proteinases contrib-
ute to the degradation of Cry proteins. Many spores are
washed off the leaf surface into the soil. There is no evi-
dence to suggest Bt is dangerous to humans and other
mammals, and indeed the studies performed thus far sug-
gest Bt is one of the safest microbial products known.
Given its extensive use, it is remarkable that only a single
injury sustained from the use of Bt products in the field
has been reported, the identification of Bt spores in the
corneal ulcer of a farmer whose face was splashed with
Dipel (Burges, 2001). Laboratory mice can survive subcuta-
neous injections of 106 spores, or 107 spores administered
intranasally (Siegel, 2001), and although limited mortality
is evident when 108 spores are delivered intranasally, this
is equivalent to an exposure level of 1012 in humans, or
one billion times higher than the maximum ever encoun-
tered in the field during spraying. Even so, concerns about
the environmental persistence of Bt spores in soil and
water have encouraged research into different formula-
tions, including pure protein crystals that are applied in
the same way as the spores. As these are even more vul-
nerable to degradation than the spores, Cry proteins have
been encapsulated in the bacterium Pseudomonas fluores-
cens (e.g. in the Mycogen products MVP which targets
lepidopteran pests and M-Trak which targets coleopteran
pests). This encapsulation strategy protects the Cry protein
Table 2 Bt topical products based on transconjugant and
recombinant strains (Baum et al., 1999)






Foil kurstaki Lepidoptera ⁄ Coleoptera
Recombinant strains
Raven Cry1Ac (x2), Cry3A
Cry3Bb (imported)
Lepidoptera
CRYMAX Cry1Ac (x3), Cry2A
Cry1C (imported)
Lepidoptera
Lepinox Cry1Aa, Cry1Ac (x2), Cry2A
Cry1F-1Ac (imported)
Lepidoptera
Table 3 Current pesticides based on Bt (modified from Kaur, 2000)









Costar kurstaki SA-12 Lepidoptera
Foil, Raven kurstaki Lepidoptera ⁄
Coleoptera




Mattch, MVP Pseudomonas Lepidoptera
Novodor, Trident tenebrionis Coleoptera
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from UV light and chemical degradation, and allows large
amounts of each Cry protein to be produced using high-
yielding expression constructs, but the bacteria do not per-
sist in soil or water for as long as Bt spores. Crop Genetics
International developed a similar strategy using Clavibacter
xyli var. cynodontis, an endophytic bacterium that can
penetrate the vascular system of plants, and this confers
resistance to the European corn borer (Lampel et al.,
1994). The advantages and disadvantages of topical appli-
cation are listed in Table 4 (Kaur, 2000).
Bacillus thuringiensis subspecies israelensis in
mosquito control
Bt var israeliensis was isolated in Israel in 1976, and was
shown to be effective against dipteran larvae including
blackflies and mosquitoes (Goldberg and Margalit, 1977).
Therefore, whereas most Bt strains have been developed
as topical pesticides for use in agriculture, Bt subsp.
israelensis has been applied to water courses and stag-
nant pools to prevent the spread of malaria (Margalith
and Ben-Dov, 2000; Fillinger et al., 2003). The toxins are
encoded by a megaplasmid called pBtoxis which contains
the genes for four Cry proteins (Cry4Aa, Cry4Ba,
Cry10Aa, Cry11Aa) and two Cyt proteins (Cyt1Aa and
Cyt2Ba) (Berry et al., 2002). The Cyt proteins interact
directly with the lipid membrane in the larval midgut and
act as receptors for the Cry toxins, so that the two act in
synergy. Product development has shown that formula-
tions containing smaller particles are the most effective
because they remain suspended for longer and are easily
ingested by the filter-feeding larvae. Heavier particles sink
and are covered in mud, quickly becoming ineffective, so
specialist products that facilitate slow release have the
best performance, e.g. products with the bacteria sus-
pended in ice chips, or formulations including Bacillus
sphaericus.
The development of Bt transgenic crops
Early development
One of the major disadvantages of topical Bt pesticides is
their short window of effectiveness, and the fact that
inclement weather can render Bt sprays useless within a
matter of hours. Topical Bt sprays must therefore be reap-
plied several times in a growing season to reach the entire
larval pest population, increasing the amount of product
that needs to be used and the fuel needed for spraying.
Furthermore, topical sprays have little impact on so-called
cryptic pests, i.e. sap sucking insects and larvae that feed
near the roots.
A potential solution to this problem was developed in
the mid-1980s when scientists introduced Bt cry genes
into tobacco and tomato plants and expressed the pro-
teins directly in plant tissues (Table 5). The Belgian com-
pany Plant Genetic Systems pioneered commercial interest
in Bt transgenic technology, but no Cry protein could be
detected in the first generation of experimental transgenic
plants (Fischhoff et al., 1987; Vaeck et al., 1987; Perlak
et al., 1991). Experiments to determine the cause of low
expression levels concentrated on differences between
prokaryotic and eukaryotic systems because recombinant
Cry proteins were expressed at high levels in heterologous
bacteria.
A large difference in average GC content was noted
between Bt and plant DNA, plus differences in codon
preference that could account for low-efficiency protein
synthesis. The bacterial genes also contained frequent
ATTTA sequences, which in plants act as signals to
increase the rate of mRNA turnover. Perlak et al. (1991)
modified the sequence of the cry1Ab and cry1Ac genes to
increase the GC content, replace sequences with four or




Harmless to humans and
other mammals
Biodegradable
Rapidly inactivated by UV light,
heat and extreme pH
Susceptible to proteases in leaf exudates
Easily removed from plant surface
by wind and rain
Therefore needs to be reapplied for full effect
Table 5 Earliest Bt transgenic plants (data from Krattiger, 1996)
Crop Bt Target pest
Tomato Gene from Bt var.
kurstaki HD-1
Lepidopteran pest: tomato
fruitworm (Heliothis zea) and
tomato pinworm (Keiferia
lycopersicella)
Truncated forms of the
gene from Bt var
kurstaki HD-1
Lepidopteran larvae
Tobacco DNA encoding a toxin





ª 2011 The Authors
Plant Biotechnology Journal ª 2011 Society for Experimental Biology, Association of Applied Biologists and Blackwell Publishing Ltd, Plant Biotechnology Journal, 9, 283–300
A century of Bacillus thuringiensis 289
more consecutive adenine or thymine residues and shift
codon preference towards that favoured by plants,
increasing protein levels by up to 100-fold and achieving
total yields equivalent to 0.02% total soluble protein
(TSP). This was still insufficient for adequate pest control,
but expression levels could be increased still further using
stronger promoters, more efficient polyadenylation and
termination signals, and by including a heterologous intron
in the expression construct. The development of synthetic
cry genes optimized for expression in plants meant that
Cry proteins were soon expressed at levels of 0.2–1% TSP
(Koziel et al., 1993) and this increased to over 5% when
cry genes were introduced into the chloroplast genome
(McBride et al., 1995).
Field trials and early commercial crops
After successful results in laboratory tests, the first field tri-
als with Bt transgenic tobacco were conducted in the Uni-
ted States and France in 1986. The plants expressed a
truncated gene encoding the N-terminal (toxic) portion of
Cry1A from Bt var kurstaki HD-73 under the control of
the constitutive Cauliflower mosaic virus 35S promoter
and protected the plants from leaf damage caused by
Helicoverpa zea, a pest known variously as cotton boll-
worm, corn earworm or tomato fruitworm, depending on
the crop it infests (Hoffmann et al., 1992). Whereas it was
never likely that the Bt tobacco variety would be devel-
oped for commercial exploitation, transgenic potato plants
expressing Cry3A from Bt var. tenebrionis were shown to
protect the crop against Colorado potato beetle in the
field much more efficiently than Cry3A topical sprays and
were earmarked for commercial development (Perlak
et al., 1993). Trials with cotton, maize and rice soon
followed (Table 6).
In 1995, the US Environmental Protection Agency
(EPA) approved the first registration of Bt potato, corn
and cotton crops. The first to reach the market was
Monsanto’s NewLeaf potato variety expressing Cry3A,
swiftly followed by two transgenic corn hybrids express-
ing Cry1Ab to protect against the European corn borer,
i.e. KnockOut by Syngenta (Basel, Switzerland) and Natu-
reGard by Mycogen (both containing event 176). Mons-
anto also released the cotton varieties Bollgard and
Ingard (events 531, 757 and 1076) expressing a modified
Cry1Ac toxin. Two additional Bt corn varieties expressing
Cry1Ab were released shortly thereafter, namely Agrisure
CB by Northrup King (event Bt11) and the widely dis-
cussed YieldGard variety (event MON 810) by Monsanto.
The early landscape of the biotech crop industry had thus
been established (Box 1). NewLeaf potato and its succes-
sors (NewLeaf Y and NewLeaf Plus) were withdrawn
from the market in 2002 (Box 2), and corn varieties con-
taining event 176 were later withdrawn and replaced
with more profitable products.
Growth and diversification of Bt crops
By 1998, the uptake of Bt crops had increased significantly
as data became available showing the positive impact of
Bt transgenic technology on agriculture and the environ-
ment (see below). In 1998, the EPA approved an insect-
resistant tomato line (event 5345) expressing Cry1Ac, and
in 2001 the Herculex corn variety jointly developed by Pio-
neer Hi-Bred (Johnston, IA) and Dow AgroSciences (India-
napolis, IN) (event TC 1507) expressing Cry1F and
protecting plants against black cutworm (Agrotis ipsilon),
fall armyworm (Spodoptera frugiperda) and the European
corn borer. A new landmark was achieved in 2002, with
the approval of Monsanto’s Bollgard II cotton (event
15985), which expressed two Bt toxins, Cry1Ac and
Cry2Ab, and later YieldGard Rootworm (event MON 863),
expressing a synthetic variant of the cry3Bb1 gene from Bt
subsp. kumamotoensis, providing resistance against the
western corn rootworm (Diabrotica virgifera virgifera). The
first stacked variety developed by crossing two previously
released Bt varieties was also released in 2003. This was
Monsanto’s YieldGard Plus (event MON 810 + MON 863),
which expressed Cry1Ab1 and Cry3Bb1. During this per-
iod, there was significant turbulence in the market as both
large and small industry players manoeuvred to acquire
strategic patents and technologies (Box 3). Tables S1–3
show, respectively, the current status of Bt patents, the
companies currently engaged in the commercial develop-
ment of Bt and the commercial status of different Bt
crops.
Table 6 Early field trials with Bt transgenic plants (data from
Hilder and Boulter, 1999)
Crop Bt toxin Target pest
Tomato Cry1A Pinworm
Tobacco Cry1A Helicoverpa zea
Potato Cry1A Tuber moth
Cry3A Colorado potato beetle
Cotton Cry1A Pink bollworm
Maize Cry1A European corn borer
Rice Cry1A Stemborers
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International expansion
The United States has enthusiastically embraced the devel-
opment of Bt agriculture and has by far the largest
amount of land in total used for Bt or Bt stacked crops.
However, Bt crops are grown in 25 other countries and
the number of countries adopting Bt crops and the
amount of land set aside for their cultivation has shown a
Box 1 Portrait of an industry
The early pioneers of commercial Bt technology were agrobiotechnology companies such as Monsanto, DuPont, Calgene and Agracetus, which had collab-
orated with academic research groups to carry out field trials and develop potential commercial products in the mid-to-late 1980s. As the 1990s
approached, these companies entered into agreements with major seed distributors such as Delta and Pine Land (DPL) to develop and test their enhanced
transgenic varieties. The predominant role of Monsanto in the early commercial landscape reflected their exclusive agreement with DPL to market trans-
genic cotton seeds internationally. Later, Monsanto forged agreements with several local companies in developing countries particularly China and India
(Huang et al., 2002a,b). Early in the 1990s, Monsanto purchased Dekalb Genetics, Asgrow and Holden’s acquiring elite germplasm through which to com-
mercialize its biotechnology products.
The Monsanto business model of assimilating companies with aligned strategic objectives was soon replicated by the other major players (see Figure
below). Although the 1990s was characterized by aggressive positioning, mergers and acquisitions, this has now given way to a more collaborative indus-
try. The recent approval of SmartStax corn, codeveloped by Monsanto and Dow AgroSciences is one example, and others include the Greenleaf Genetics
collaboration between Syngenta and Pioneer Hi-Bred International, and Monsanto licensing RoundupReady events to Syngenta so that the trait can be
incorporated into their hybrids (Marra et al., 2010).
Figure in Box 1 Evolution of the commercial landscape for Bt crops. The five major companies currently selling Bt seeds have arisen through
a series of mergers, acquisitions and spin offs ⁄ demergers as larger companies segregate their agribusiness interests. Monsanto Co., in its cur-
rent incarnation, was an agribusiness spin-off from Pharmacia in 2002 following the merger of the original Monsanto Co. (established in 1901)
with Pharmacia and Upjohn in 2000. Pharmacia created the new Monsanto as an agribusiness subsidiary in late 2000, and then established it
as an independent company in 2002. Bayer CropScience is an agribusiness subsidiary of Bayer AG, formed following the acquisition of Aventis
CropScience in 2000. Syngenta formed from the merger of Novartis and AstraZeneca in 2000, both of which were agribusiness spin-offs gen-
erated in previous mergers. Dow AgroSciences is a wholly owned subsidiary of Dow Chemical Co., formed when Dow Chemical Co. purchased
Eli Lilly’s stake in Dow Elanco (an agribusiness spin-off from Dow Chemical Co. and Ely Lily & Co. formed in 1989). Finally, Pioneer Hi-Bred
International is now an agribusiness subsidiary of DuPont, which acquired 20% of the company in 1997 and the remaining 80% in 1999.
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Box 2 The demise of NatureMark
NatureMark was a subsidiary of Monsanto created by the company in 1996 to market its new transgenic potato lines, beginning with NewLeaf (contain-
ing the gene for Cry3Aa) and subsequently NewLeaf Y (containing the Bt gene and an additional gene conferring resistance to Potato virus Y ) and New-
Leaf Plus (containing the Bt gene and an additional gene conferring resistance to Potato leaf roll virus). Despite rapid take up and hugely favourable
responses from growers, all the potato lines and the NatureMark brand itself were abandoned in 2002 after a highly successful potato growing season
in 2001. Why did this happen?
The NatureMark story shows how misguided activism can have disastrous effects. Activists began a very public campaign of misinformation against
Monsanto’s potato products in 1999 and soon had the support of several major convenience food providers including McDonalds, which banned geneti-
cally engineered crops from its food to avoid negative publicity. This in turn put pressure on potato processers and growers, who had little choice but to
cancel contracts for transgenic potatoes they would not be able to sell. The transgenic varieties had all received appropriate clearance from the regulators
and were safe for human consumption, so it is clear that the entire chain of events was based on hysteria and not one shred of scientific evidence. Not-
withstanding the above, Monsanto was forced to abandon NatureMark and all potato-related research and development as there would be no market
for its products. The activists were successful, but it was a Pyrrhic victory. In their haste to save the environment by getting rid of ‘unnatural’ vegetables,
they ensured that tons of chemical pesticides would be required for future potato crops and tons of fuel would be required to spray them; they ensured
that farmers in North America would mourn the loss of a superior product, lose profit and make the agricultural sector as a whole less profitable; and
they ensured that many additional beneficial crops would never see the light of day, or would be developed instead in other countries.
Figure in Box 2 NewLeaf Plus field (left) is protected from Potato leaf roll virus (PLRV) without sprays. No infection is evident. The conventional
potato field on the right is 100% PLRV infected, despite sprays. Figure used with permission from Peter Thomas.
Box 3 War and peace
Many aspects of Bt technology fall under the scope of intellectual property and can be protected with patents, although many of these aspects (process-
ing and formulation in the case of Bt sprays, gene transfer and expression in the case of Bt crops) are not specific to Bt and can have wider ramifications.
Many companies and academic departments working on Bt technology have sought patents, and in 1996 when the first Bt crops were commercialized
these were divided more or less equally between the ‘old guard’ companies that had developed Bt topical products and the ‘new wave’ of companies
expressing Bt genes in plants. Nearly 60% of the approximately 400 Bt patents were owned by Mycogen, Novartis, Abbot, Toa, AgrEvo, Ecogen, Mons-
anto and Zeneca. It is noteworthy that the five major companies involved in Bt crop development today have, since 1996, engaged in many cooperative
research and development agreements and this has continued to the present day. However, they have also litigated extensively to prevent patent
infringements. The figure below shows current and past collaborations and licensing deals whereas the arrows show litigation pursued either by the com-
pany as it exists today, or one of its predecessors. The current Bt patent landscape is summarized in Table S1.
Figure in Box 3 Early patent wars (arrows show litigation) and collaborations (dotted lines) in the commercialization of Bt.
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continued upward trend for 15 years (Figure 3). Bt agricul-
ture is expanding on every continent except Europe, which
persists with its absurdly byzantine approach to all geneti-
cally engineered crops. Remarkably, the small African
nation of Burkino Faso grows more Bt crops than the
whole of Europe. The total global area devoted to Bt crops
in 2009 was >50 million hectares (36% of all biotech
crops), made up of 21.7 million hectares of Bt-only crops
and 28.7 million hectares of crops with Bt stacked with
herbicide tolerance (James, 2010).
Although Argentina and Brazil currently hold second
and third place in the global rankings for Bt agriculture,
China and India have seen the most rapid adoption. This
is because both are major growers of cotton, and China in
particular is a major grower of rice. Field trials of Bt rice
were first conducted in China in 1998. A series of trans-
genic Bt rice lines transformed with modified cry1A,
cry1Ab and cry1Ac genes were assessed in large-scale tri-
als in 2007 (Huang et al., 2007) and were approved for
commercial release in November 2009, although large-
scale cultivation is still pending.
Ecological aspects of Bt crops
Potential for the evolution of resistant insect
populations
All insecticides create selection pressure on target popula-
tions, and the mode of action of Bt toxins (binding to a
specific receptor on midgut epithelial cells) presents a clear
opportunity for pests to evolve resistance. The first
evidence of this process was observed in 1985, when
resistant mealmoths (Plodia interpunctella) were found in
grain stores that had been sprayed with Bt spores. The
selection pressure was recreated in the laboratory, showing
the evolution of resistant strains after 15 generations of
sublethal selection (McGaughey, 1985). Resistance was also
observed in wild populations of the diamondback moth
(Plutella xylostella) feeding on watercress in Hawaii that
had been sprayed with Bt up to 400 times (Liu and Tabash-
nik, 1997). Laboratory experiments were able to produce
Bt-resistant varieties of several additional species that had
not evolved resistance in the wild, suggesting that the
intensive use of single Cry proteins was likely to result in
the evolution of resistant strains (Tabashnik et al., 2005).
The Bt crop industry is aware of the danger of resistant
pests, and many seed vendors insist on customer agree-
ments that mandate the use of preventative measures,
particularly the refugia strategy in which a proportion of
any field containing Bt crops must be planted with the
nontransgenic variety to encourage the breeding of nonre-
sistant pests. The widespread use of this strategy is proba-
bly responsible for the remarkable lack of resistant
populations even in areas devoted to high-intensity Bt
agriculture for 15 years. Tabashnik and coworkers have
studied pest populations on Bt sites in the United States,
Australia, China and Europe and have found that among
six major insect pests, field resistance occurred in only one
species (H. zea) and only at a limited number of sites in
Arkansas and in Mississippi, not in, for example, North
Carolina, where the refuge areas are typically larger (Ta-
bashnik et al., 2008). The prolonged efficacy of the first
generation of Bt crops for more than a decade against
nearly all targeted pest populations has exceeded the
Figure 3 Sharing out the Bt pie. More than 50 million hectares of Bt crops were grown commercially in 2008, the vast majority (>33 million
hectares) in the USA. India, China, Argentina, Brazil, South Africa, Canada, Philippines, Australia and Uruguay were (in descending order by land
area) the other countries to grow >100 000 hectares. The minor growers (in descending order by land area) were Spain, Mexico, Colombia,
Honduras, Burkino Faso, Czech Republic, Romania, Portugal, Germany, Poland, Slovakia and Egypt. The data include Bt-only crops and Bt stacked
with other traits. Source: Brookes and Barfoot (2010).
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expectations of many entomologists working on popula-
tion genetics (Bourguet, 2004). Although integrated pest
management strategies have been carefully implemented
by growers, the absence of resistant populations in the
wild suggests that resistance may attract a fitness penalty
in the absence of the toxin (Sanchis and Bourguet, 2008).
Although current refugia strategies have worked better
than anticipated, a number of alternative or complemen-
tary approaches have been proposed to address the possi-
bility of resistance evolving in target pests. High-dose and
low-dose approaches aim in one case to overwhelm insect
populations with immense toxin doses so that there is no
chance to evolve resistance, and in the other case merely
to make them more susceptible to predators, but both
make many assumptions and would be difficult to imple-
ment in the field (Gould, 1994). Similarly, targeted expres-
sion (e.g. wound-inducible expression) or temporally
restricted expression would provide the same advantages
of a refugia but would be more difficult to implement.
A more robust approach is resistance pyramiding, i.e. the
stacking of multiple genes in the same plant that target
the same pest via different mechanisms. In theory, resis-
tance against one Cry protein could arise through a single
point mutation in the gene encoding its receptor. Experi-
ments have shown that mutations affecting the secondary,
high-affinity Cry toxin receptors do not induce resistance,
but multiple resistance alleles can be identified in the
cadherin genes encoding the primary receptors (Sobero´n
et al., 2009; Zhao et al., 2010). However, the chances of
two mutations arising simultaneously in the receptors for
two independently acting toxins would be much lower.
This is probably why mosquito strains resistant to Bt var
israelensis have not evolved despite many years of
deployment—the toxin crystals in this case comprise five
different toxins, one of which is Cyt1A which, as discussed
above, has a different action mechanism to the three-
domain Cry toxins. Pyramiding resistance crops are there-
fore likely to require smaller refuges (Shelton et al., 2002).
The pyramiding strategy is supported by laboratory tests
with cotton bollworm and the recent analysis of pink boll-
worm (Pectinophora gossypiella) populations in Bt cotton
fields in India. The laboratory studies showed that cotton
bollworm can evolve resistance to MVP, a commercial Bt
formulation based on Cry1Ac, but not to DiPel or XenTari,
which contain multiple Cry proteins (Akhurst et al., 2003).
The resistant strain was also resistant to Cry1Ab (which
binds to the same receptor as Cry1Ac in cotton bollworm)
but not to Cry2Aa or Cry2Ab which bind different recep-
tors (Liao et al., 2002). Field monitoring of pink bollworm
in 2009 showed that the pest evolved resistance to Boll-
gard I cotton (Cry1Ac) in four areas of Gujarat: Amreli,
Bhavnagar, Junagarh and Rajkot. However, no resistance
was observed in fields growing the Bollgard II variety,
which contains Cry1Ac and Cry2Ab (Monsanto, 2010).
Attempts have also been made to enhance toxin activity
by coexpression or protein fusion. One example is the
expression of Cry toxins along with fragments of their
receptors, which can potentiate their activity by allowing
them to assemble into pore-forming complexes immedi-
ately (Chen et al., 2007). The fusion of two or more toxins
has been used to generate artificial hybrids with a host
range differing from that of the parent toxins. For exam-
ple, Naimov et al. (2003) created a fusion toxin comprising
a truncated version of Cry1Ba and domain II from Cry1Ia.
Desiree potato plants expressing this recombinant toxin
were the first Bt plants resistant to both coleopteran and
lepidopteran pests [Colorado potato beetle, potato tuber
moth (Phthorimaea operculella) and European corn borer]
and the hybrid protein did not compete for binding sites
with either of the parent toxins, indicating it bound to a
distinct receptor. More recently, Walters et al. (2010) cre-
ated a hybrid Cry1Ab ⁄Cry3A toxin (eCry3.1Ab) which was
toxic to the western corn rootworm, a pest unaffected by
either of the parent toxins. In a related approach, Mehlo
et al. (2005) fused the Cry1Ac toxin to the galactose-bind-
ing domain of the nontoxic ricin B-chain, again expanding
its repertoire of potential receptors and therefore broaden-
ing its host range. Transgenic rice and maize plants
expressing the fusion protein were significantly more toxic
in insect bioassays than those containing the Bt gene
alone. They were also resistant to a wider range of insects,
including important pests that are not normally susceptible
to Bt toxins.
Environmental impact
Although there is much debate both politically and publical-
ly concerning the environmental impact of genetically engi-
neered crops, it is clear that Bt crops have provided
immense environmental benefits. The deployment of Bt
crops has reduced the use of pesticides, also saving on fossil
fuels required for spraying, reducing CO2 emissions by limit-
ing the need for ploughing, and conserving soil and mois-
ture by encouraging no-tilling agriculture. The cumulative
reduction in pesticide use for the period 1996–2008 was
approximately 356 000 tonnes (8.4%), which is equivalent
to a 16.1% reduction in the associated net environmental
impact as measured by the environmental impact quotient
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(EIQ). The corresponding data for 2008 alone revealed a
reduction of 34 600 tonnes of pesticides (9.6%) and a
reduction of 18.2% in EIQ (Brookes and Barfoot, 2010). In
countries such as India, China, Argentina and Brazil, which
are the most enthusiastic adopters of Bt agriculture after
the United States, the greatest impact of Bt has been the
reduction in the number of pesticide sprays (from 16 down
to 2–3 per growing season) and a concomitant reduction in
the number of poisonings caused by chemical exposure.
These factors, together with average yield increases of up
to 10%, have raised net income by as much as 40% (Subra-
manian and Qaim, 2010).
Although the reduction in pesticide use has been bene-
ficial to the environment and the economy, concern has
been expressed that the use of Bt transgenic plants could
affect beneficial insects, upset the balance of natural eco-
systems and encourage the breeding of secondary pests. It
is unclear why those raising such concerns are not equally
concerned about the impact of topical Bt sprays and
chemical pesticides on these populations, because sprays
are the only current alternative to transgenic crops that
will guarantee adequate food production.
Beneficial insects
The potential impact of Bt crops on beneficial insects was
brought into focus by the now discredited Monarch but-
terfly study, which suggested Monarch larvae feeding on
leaves covered in pollen shed from Bt maize plants (event
Bt176) did not grow as rapidly as those feeding on uncon-
taminated leaves. This report was seized on by opponents
of genetic engineering technology and is still routinely
cited as an argument against the deployment of Bt crops
despite follow-up studies finding no evidence for a statisti-
cally significant effect. What other evidence is there
regarding the impact of Bt crops on nontarget insects?
Field studies on the NewLeaf potato (Cry3Aa) showed
that the toxin specifically affects the Colorado potato bee-
tle and has no deleterious effect on other insects in the
potato field, including the beetle’s natural predators. In
contrast, chemical sprays killed both the beetle and its
predators, leading to an explosion in the population of
vectors carrying viral pathogens, thus increasing the risk of
potato virus diseases (Reed et al., 2001). Any impact on
natural predators that normally keep pest populations in
check could have knock-on effects throughout the food
web, so careful studies of these effects are required (Dut-
ton et al., 2002). One such study looked at nontarget
arthropod predators in Bt maize fields (specifically events
MON 810 expressing Cry1Ab, MON 88017 expressing
Cry3Bb1 and a stacked variety MON 89034 · MON
88017, expressing Cry1A105, Cry2Ab2 and Cry3Bb1). The
study showed that the predator and alternative prey popu-
lations naturally adjusted to reflect the absence of the tar-
geted pest (Faria et al., 2007). Bt maize increased the
population of corn aphid (Rhopalosiphum maidis) which
resulted in more honey dew synthesis, which increased
the number and longevity of the lepidopteran larval para-
sitoid Cotesia marginiventris. Bt cotton appears to have no
effect on the cotton aphid (Aphis gossypii) population,
and the Bt toxin was not detected in the honey dew,
which is an energy source for many arthropod species
including predators and parasitoids. Bt cotton therefore
has no negative impact on beneficial insects in the cotton
ecosystem (Lawo et al., 2009).
Secondary pests
A secondary pest is a pest species whose numbers are
usually kept in check by the presence of a primary pest,
such that no control measures are necessary. However,
elimination of the major pest may elevate the secondary
pest to primary status, perhaps even affecting surrounding
crops that are not usually troubled by either the primary
or secondary pest species. Cotton bollworm is a primary
pest of cotton, and it suppresses the population of mirid
bugs, i.e. homopteran insects that feed on plant sap. Bt
cotton represents approximately 95% of all cotton in
Northern China and is lethal to the cotton bollworm at
the larval stage, so a study was carried out to look at any
impact on mirid bug populations (Lu et al., 2010). The
study showed that mired bug populations have not
increased in nontransgenic cotton because the species is
controlled by broad-spectrum pesticides that are also used
to kill bollworm larvae. In Bt cotton, the mirid bug popula-
tion has increased every year from 1997 to 2008 and has
gained the status of a primary pest, a phenomenon that is
now impacting on unrelated crops such as dates, grape-
vine, apple, peach and pear. Although this is an undesir-
able outcome, it is somewhat balanced by the increased
insect biodiversity observed in Bt cotton in China. Field
studies revealed 31 insect species in Bt plots (23 beneficial)
compared to 14 species in non-Bt plots, and only five of
which were beneficial (Pray et al., 2002).
Environmental diversity
In addition to insect populations, it is useful to study the
impact of Bt on other parts of the ecosystem, particularly
the soil as this is where Bt spores end up when washed
from the plant surface, and is the destination of Bt toxins
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exuded from plant roots, released from pollen grains and
released from decaying or residual plant biomass ploughed
into the soil. Earthworms (oligochaetes) are good indica-
tors of general soil health and comparisons of earthworm
numbers in plots containing nontransgenic maize and Bt
maize expressing cry1Ab (events Bt11 and MON 810) and
cry3Bb1 (event MON 863) over 4 years showed no differ-
ences in development or biomass (Zeilinger et al., 2010).
More earthworms were found within the rows of maize
plants than between them in all plots, perhaps because
the soil is lighter and has more biological activity and
therefore represents a better source of nutrients.
Looking to the future
The first generation of Bt crops has been extraordinarily
successful, with a few examples of pest populations evolv-
ing resistance. These crops are already being supplanted
with second-generation varieties with more resilient traits
generated by stacking and pyramiding resistance genes.
Even so, this is not the time to be complacent and the
search for more efficacious and potent strains must con-
tinue (Christou et al., 2006; Crickmore, 2006). New strains
of Bt are reported on a regular basis, especially now prote-
omics methods can be used to screen for novel toxins on
a large scale. Sun and Park (2010) recently identified
Cry60Ba from Bt serovar malayensis in a search for
mosquitocidal toxins, and Zhang et al. (2010) recently
isolated strain LLP29 from the phylloplane of Magnolia
denudate, identifying a novel toxin (Cyt1Aa6) which is
lethal to mosquito larvae. Homologous genes have also
been identified in related bacteria, reflecting the fact that
Cry proteins are members of a diverse superfamily.
Strain engineering efforts have continued to extend the
Bt host range. For example, Liu et al. (2010) recently
reported the construction of strain BIOT185 from the origi-
nal strains HBF-1 and BTO 185 that express Cry8ca2 and
Cry8Ea1, respectively. The new strain is toxic towards
scarab insects such as Atractaspis corpulenta. Similarly,
Wang et al. (2008) constructed a new strain by introducing
the cry3Aa7 gene into the UV17 strain, which produces
Cry1Aa, Cry1Ac, Cry1Ca and Cry2Ab. The new strain was
toxic to both lepidopteran and coleopteran insects.
The toxicity of Cry proteins can be enhanced by amino
acid substitutions, the introduction of cleavage sites in
specific regions of the protein and the deletion of small
fragments from the N-terminal region (Pardo-Lo´pez et al.,
2009). For example, replacing residue N372 in Cry1Ab
domain II with alanine or glycine increases its toxicity to
the gypsy moth (Lymantria dispar) eightfold by inducing a
fourfold increase in binding affinity to its receptor (Raj-
amohan et al., 2006). More recently, Mun˜o´z-Garay et al.
(2009) produced an engineered Cry1AMod toxin lacking
helix a-1, which did not need to bind the receptor cadher-
Figure 4 Nine common pests of rice, cotton and maize that are controlled by Bt crops. Top row from left (rice pests): yellow stem borer
(Scirpophaga incertulas), rice leaffolder (Lerodea eufala), striped stem borer (Chilo suppressalis). Middle row from left (cotton pests): pink bollworm
(Pectinophora gossypiella), tobacco budworm (Heliothis virescens), American bollworm (Helicoverpa armigera). Bottom row from left (maize pests):
European corn borer (Ostrinia nubilalis), fall armyworm (Spodoptera frugiperda), northern corn rootworm (Diabrotica barberi). Image sources
from top left: (i) IRRI, (ii) IRRI, (iii) Bayer CropScience, (iv) USDA, (v) Cotton Corporation of India Ltd., (vi) USDA, (vii) Frank Peairs, Colorado State
University, Bugwood.org, (viii) Canadian Biodiversity Information Facility, (ix) Plant Management Network.
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in and therefore killed even insects that were resistant to
the parent toxin, Cry1Ab.
The commercial environment for stacked and pyramid-
ing traits in Bt crops was given a boost in 2010 with the
approval of SmartStax corn, codeveloped by Monsanto
and Dow AgroSciences. Approvals were granted in the
United States, Canada, Japan, Mexico, The Philippines, Tai-
wan and South Korea (Marra et al., 2010). SmartStax was
created by crossing several existing varieties to stack all
the events (MON 89034 · TC 1507 · MON 88017 · DAS-
59122-7) in one line. SmartStax corn contains eight
transgenes, including six Bt genes offering a broad spec-
trum of pest resistance above and below ground, while
still retaining the specificity of each toxin. The specific tox-
ins are Cry1A.105, Cry2Ab, Cry3Bb1, Cry34Ab1,
Cry35Ab1 and Cry1Fa2, providing resistance to a long list
of coleopteran and lepidopteran pests (Figure 4), including
the European corn borer, south-western corn borer (Diat-
raea grandiosella), southern cornstalk borer (Diatraea
crambidoides), corn earworm, fall armyworm, stalk borer
(Papaipema nebris), lesser corn stalk borer (Elasmopalpus
lignosellus), sugarcane borer (Diatraea saccharalis), wes-
tern bean cutworm (Striacosta albicosta), black cutworm,
western corn rootworm, northern corn rootworm (Diabro-
tica barberi) and Mexican corn rootworm (Diabrotica virgif-
era zeae), combining this with tolerance to two different
broad-spectrum herbicides (glyphosate and glufosinate).
The refuge requirement for SmartStax corn is just 5%.
The first 100 years of Bt topical sprays and transgenic
crops have been extraordinarily successful and advanta-
geous, with a strong record in terms of safety, efficacy
and environmental beneficence, and the ability to bring
economic prosperity in both developing countries and the
industrialized west. Recent reports show that work contin-
ues to identify and create novel Bt strains and toxins with
more potent and specific effects, and to generate trans-
genic plant lines that suppress agricultural pests and
reduce opportunities for the evolution of resistant strains
while conferring no harm on beneficial insects or soil
organisms. This unique combination of benefits will con-
tinue to provide farmers and health professionals with the
weapons they need to fight pests and insect-borne dis-
eases, maintaining crop yields and improving the health of
the world’s growing population.
Acknowledgements
Research in our laboratory is supported by Ministry of Sci-
ence and Innovation-MICINN (Grant BFU2007-61413);
European Research Council Advanced Grant BIOFORCE;
Center Consolider, MICINN, Spain; COST Action FA0804;
Associated Unit CAVA; and SmartCell, FP7 Integrated
Project.
References
Akhurst, R.J., James, W., Bird, L.J. and Beard, C. (2003)
Resistance to the Cry1Ac d-endotoxin of Bacillus thuringiensis in
the cotton bollworm, Helicoverpa armigera (Lepidoptera:
Noctuidae). J. Econ. Entomol. 96, 1290–1299.
Arantes, O. and Lereclus, D. (1991) Construction of cloning
vectors for Bacillus thuringiensis. Gene, 108, 115–119.
Aronson, A. (2002) Sporulation and delta-endotoxin synthesis by
Bacillus thuringiensis. Cell. Mol. Life Sci. 59, 417–425.
Baum, J.A., Johnson, T.B. and Carlton, B.C. (1999) Bacillus
thuringiensis. Natural and recombinant bioinsecticide products.
Methods Biotechnol. 5, 189–209.
Berry, C., O’Neil, S., Ben-Dov, E., Jones, A.F., Murphy, L., Quail,
M.A., Holden, M.T.G., Harris, D., Zaritsky, A. and Parkhill, J.
(2002) Complete sequence and organization of pBtoxis, the
toxin-coding plasmid of Bacillus thuringiensis subsp. israelensis.
Appl. Environ. Microbiol. 68, 5082–5095.
Boonserm, P., Mo, M., Angsuthanasombat, C. and Lescar, J.
(2006) Structure of the functional form of the mosquito
larvicidal Cry4Aa toxin from Bacillus thuringiensis at a 2.8-
angstrom resolution. J. Bacteriol. 188, 3391–3401.
Bourguet, D. (2004) Resistance to Bacillus thuringiensis toxins in
the European corn borer: what chance for Bt maize? Physiol.
Entomol. 29, 251–256.
Brookes, G. and Barfoot, P. (2010) GM Crops: Global Socio-
economic and Environmental Impacts 1996–2008. Dorchester,
UK: PG Economics Ltd.
Burges, H.D. (2001) Bacillus thuringiensis in pest control: now and
the future. Pest Outlook, 12, 90–97.
Burges, H.D. and Jones, K.A. (1998a) Formulation of bacteria,
viruses and protozoa to control insects. In Formulation of
Microbial Biopesticides, Beneficial Microorganisms. Nematodes
and Seed Treatments (Burges, H.D., ed), pp. 33–127.
Dordrecht: Kluwer Academic Publishers.
Burges, H.D. and Jones, K.A. (1998b) Trends in formulation of
microorganisms and future research requirements. In
Formulation of Microbial Biopesticides, Beneficial
Microorganisms, Nematodes and Seed Treatments (Burges, H.D.,
ed), pp. 311–332. Dordrecht: Kluwer Academic Publishers.
Carlton, B.C. and Gawron-Burke, C. (1993) Genetic improvement
of Bacillus thuringiensis for bioinsecticide development. In
Advanced Engineered Biopesticides (Kim, L., ed), pp. 43–61.
NY: Marcel Dekker Inc.
Carlton, B.C. and Gonzalez, J.M. (1985) Plasmids and delta-
endotoxin production in different subspecies of Bacillus
thuringiensis. In Molecular Biology of Microbial Differentiation
(Hoch, J.A. and Setlow, Q., eds), pp. 246–252. Washington DC:
American Society for Microbiology.
Chen, J., Hua, G., Jurat-Fuentes, J.L., Abdullah, M.A. and Adang,
M.J. (2007) Synergism of Bacillus thuringiensis toxins by a
fragment of a toxin-binding cadherin. Proc. Natl Acad. Sci.
U S A, 104, 13901–13906.
ª 2011 The Authors
Plant Biotechnology Journal ª 2011 Society for Experimental Biology, Association of Applied Biologists and Blackwell Publishing Ltd, Plant Biotechnology Journal, 9, 283–300
A century of Bacillus thuringiensis 297
Christou, P., Capell, T., Kohli, A., Gatehouse, J.A. and Gatehouse,
A.M.R. (2006) Recent developments and future prospects in
insect pest control in transgenic crops. Trends Plant Sci. 11,
302–308.
Crickmore, N. (2006) Beyond the spore – past and future
developments of Bacillus thuringiensis as a biopesticide. J. Appl.
Microbiol. 101, 616–619.
Crickmore, N., Zeigler, D.R., Feitelson, J., Schnepf, E., Van Rie, J.,
Lereclus, D., Baum, J. and Dean, D.H. (1998) Revision of the
nomenclature for the Bacillus thuringiensis pesticidal crystal
proteins. Microbiol. Mol. Biol. Rev. 62, 807–813.
Crickmore, N., Zeigler, D.R., Schnepf, E., Van Rie, J., Lereclus, D.,
Baum, J., Bravo, A. and Dean, D.H. (2010) Bacillus thuringiensis
toxin nomenclature. http://www.lifesci.sussex.ac.uk/Home/
Neil_Crickmore/Bt/.
Dutton, A., Klein, H., Romies, J. and Bigler, F. (2002) Uptake of
Bt toxin by herbivores feeding on transgenic maize and
consequences for the predator Chrysoperla cornea. Ecol.
Entomol. 27, 441–447.
Faria, C.A., Wa¨ckers, F.L., Pritchard, J., Barrett, D.A. and Turlings,
T.C. (2007) High susceptibility of Bt maize to aphids enhances
the performance of parasitoids of lepidopteran pests. PLoS
ONE, 2, e600.
Fillinger, U., Knols, B.G.J. and Becker, N. (2003) Efficacy and
efficiency of new Bacillus thuringiensis var. israelensis and
Bacillus sphaericus formulations against Afrotropical
anophelines in Western Kenya.Trop. Med. Int. Health, 8, 37–47.
Fischhoff, D.A., Bowdish, K.S., Perlak, F.J., Marrone, P.G.,
McCormick, S.M., Niedermeyer, J.G., Dean, D.A., Kusano-
Kretzmer, K., Mayer, E.J., Rochester, D.E., Rogers, S.G. and
Fraley, R.T. (1987) Insect tolerant transgenic tomato plants.
Nature Biotechnol. 5, 807–813.
Goldberg, L.H. and Margalit, J. (1977) A bacterial spore
demonstrating rapid larvicidal activity against Anopheles
sergentii, Uranotaenia unguiculata, Culex inivitattos, Aedes
aegypti and Culexpipiens. Mosq. News, 37, 355–358.
Gonza´lez, J.M., Brown Jr, B.J. and Carlton, B.C. (1982) Transfer
of Bacillus thuringiensis plasmids coding for delta-endotoxin
among strains of B. thuringiensis and B. cereus. Proc. Natl
Acad. Sci. U S A, 79, 6951–6955.
Gould, F. (1994) Potential and problems with high-dose strategies
for pesticidal engineered crops. Biocontrol Sci. Technol. 4, 451–
461.
Hilder, V.A. and Boulter, D. (1999) Genetic engineering of crop
plants for insect resistance – a critical review. Crop Prot., 18,
177–191.
Hoffmann, M.P., Zalom, F.G., Wilson, L.T., Smilanick, J.M., Malyj,
L.D., Kiser, J., Hilder, V.A. and Barnes, W.M. (1992) Field
evaluation of transgenic tobacco containing genes encoding
Bacillus thuringiensis delta-endotoxin or cowpea trypsin
inhibitor: efficacy against Helicoverpa zea (Lepidoptera:
Noctuidae). J. Econ. Entomol. 85, 2516–2522.
Huang, J., Pray, C. and Rozelle, S. (2002a) Enhancing the crops to
feed the poor. Nature, 418, 678–684.
Huang, J., Rozelle, S., Pray, C. and Wang, Q. (2002b) Plant
biotechnology in China. Science, 295, 674–676.
Huang, D.-F., Zhang, J., Song, F.-P. and Lang, Z.-H. (2007)
Microbial control and biotechnology research on Bacillus
thuringiensis in China. J. Invertebr. Pathol. 95, 175–180.
Husz, B. (1930) Field experiments on the application of Bacillus
thuringiensis against the corn borer. Int. Corn Borer Invest. Sci.
Rep. 3, 91–98.
James, C. (2010) Global Status of Commercialized Biotech ⁄GM
Crops: 2009. ISAAA Brief 41-2009. Ithaca, NY: ISAAA.
Kaur, S. (2000) Molecular approaches towards development of
novel Bacillus thuringiensis biopesticides. World J. Microbiol.
Biotechnol. 16, 781–793.
Koziel, M.G., Beland, G.L., Bowman, C., Carozzi, N.B.,
Crenshaw, R., Crossland, L., Dawson, J., Desai, N., Hill, M.,
Kadwell, S., Launis, K., Lewis, K., Maddox, D., McPherson,
K., Meghji, M.R., Merlin, E., Rhodes, R., Warren, G.W.,
Wright, M. and Evola, S.V. (1993) Field performance of elite
transgenic maize plants expressing an insecticidal protein
derived from Bacillus thuringiensis. Nature Biotechnol. 11,
194–200.
Krattiger, A.F. (1996) Insect Resistance in Crops: A Case Study of
Bacillus thuringiensis (Bt) and its Transfer to Developing
Countries. ISAAA Briefs No. 2. Ithaca, NY: ISAAA.
Kronstad, J.W., Schnepf, H.E. and Whiteley, H.R. (1983) Diversity
of locations for Bacillus thuringiensis crystal protein genes.
J. Bacteriol. 154, 419–428.
Kuo, W.S. and Chak, K.F. (1996) Identification of novel cry-type
genes from Bacillus thuringiensis strains on the basis of
restriction fragment length polymorphism of the PCR-amplified
DNA. Appl. Environ. Microbiol. 62, 1369–1377.
Lampel, J.S., Canter, G.L., Dimock, M.B., Kelly, J.L., Anderson,
J.J., Uratani, B.B., Foulke Jr, J.S. and Turner, J.T. (1994)
Integrative cloning, expression, and stability of the cry1A(c)
gene from Bacillus thuringiensis subsp. kurstaki in a
recombinant strain of Clavibacter xyli subsp. cynodontis. Appl.
Environ. Microbiol. 60, 501–508.
Lawo, N.C., Wa¨ckers, F.L. and Romeis, J. (2009) Indian Bt cotton
varieties do not affect the performance of cotton aphids. PLoS
ONE, 4, e4804.
Liao, C., Heckel, D.G. and Akhurst, R. (2002) Toxicity of Bacillus
thuringiensis insecticidal proteins for Helicoverpa armigera and
Helicoverpa punctigera (Lepidoptera: Noctuidae), major pests of
cotton. J. Invertebr. Pathol. 80, 55–63.
Liu, Y.B. and Tabashnik, B.E. (1997) Experimental evidence that
refuges delay insect adaptation to Bacillus thuringiensis. Proc. R.
Soc. Lond. B, 264, 605–610.
Liu, J., Yan, G., Shu, C., Zhao, C., Liu, C., Song, F., Zhou, L., Ma,
J., Zhang, J. and Huang, D. (2010) Construction of a Bacillus
thuringiensis engineered strain with high toxicity and broad
pesticidal spectrum against coleopteran insects. Appl. Microbiol.
Biotechnol. 87, 243–249.
Lu, Y., Wu, K., Jiang, Y., Xia, B., Li, P., Feng, H., Wyckhuys, K.A.
and Guo, Y. (2010) Mirid bug outbreaks in multiple crops
correlated with wide-scale adoption of Bt cotton in China.
Science, 328, 1151–1154.
de Maagd, R.A., Bravo, A. and Crickmore, N. (2001) Bacillus
thuringiensis has evolved specific toxins to colonize the insect
world. Trends Genet. 17, 193–199.
Margalith, Y. and Ben-Dov, E. (2000) Biological control by
Bacillus thuringiensis subsp. israelensis. In Insect Pest
Management: Techniques for Environmental Protection
(Rechcigl, J.E. and Rechcigl, N.A., eds), pp. 243–301. Boca
Raton FL: CRC Press.
ª 2011 The Authors
Plant Biotechnology Journal ª 2011 Society for Experimental Biology, Association of Applied Biologists and Blackwell Publishing Ltd, Plant Biotechnology Journal, 9, 283–300
Georgina Sanahuja et al.298
Marra, M.C., Piggott, N.E. and Goodwin, B.K. (2010) The
anticipated value of SmartStax for US corn growers.
AgBioForum, 13, 1. article 1.
Mattes, O. (1927) Parasitare Krankheiten der Mehlmottenlarven
und Versuche uber ihre Verwendbarkeit als biologisches
Bekiampfungsmittel. Sitzber. Ges. Beforder. Ges. Naturw.
Marburg. 62, 381–417.
McBride, K.E., Svab, Z., Schaaf, D.J., Hogan, P.S., Stalker, D.M.
and Maliga, P. (1995) Amplification of a chimeric Bacillus gene
in chloroplasts leads to an extraordinary level of an insecticidal
protein in tobacco. Nature Biotechnol. 13, 362–365.
McGaughey, W.H. (1985) Insect resistance to the biological
insecticide Bacillus thuringiensis. Science, 229, 193–195.
Mehlo, L., Gahakwa, D., Nghia, P.T., Loc, N.T., Capell, T.,
Gatehouse, J.A., Gatehouse, A.M. and Christou, P. (2005) An
alternative strategy for sustainable pest resistance in genetically
enhanced crops. Proc. Natl Acad. Sci. U S A, 102, 7812–7816.
Monsanto, C. (2010) Press release, 5th March 2010. Available on-
line at: http://www.monsanto.com/newsviews/Pages/india-pink-
bollworm.aspx.
Mun˜o´z-Garay, C., Portugal, L., Pardo-Lo´pez, L., Jime´nez-Jua´rez,
N., Arenas, I., Go´mez, I., Sa´nchez-Lo´pez, R., Arroyo, R.,
Holzenburg, A., Savva, C.G., Sobero´n, M. and Bravo, A.
(2009) Characterization of the mechanism of action of the
genetically modified Cry1AbMod toxin that is active against
Cry1Ab-resistant insects. Biochim. Biophys. Acta, 1788, 2229–
2237.
Naimov, S., Dukiandjiev, S. and de Maagd, R.A. (2003) A hybrid
Bacillus thuringiensis delta-endotoxin gives resistance against a
coleopteran and a lepidopteran pest in transgenic potato. Plant
Biotechnol. J. 1, 51–57.
Pardo-Lo´pez, L., Mun˜oz-Garay, C., Porta, H., Rodrı´guez-Almaza´n,
C., Sobero´n, M. and Bravo, A. (2009) Strategies to improve the
insecticidal activity of Cry toxins from Bacillus thuringiensis.
Peptides, 30, 589–595.
Perlak, F.J., Fuchs, R.L., Dean, D.A., McPherson, S.L. and Fischoff,
D.A. (1991) Modification of the coding sequence enhances
plant expression of insect control genes. Proc. Natl Acad. Sci. U
S A, 88, 3324–3328.
Perlak, F.J., Stone, T.B., Muskopf, Y.M., Petersen, L.J., Parker,
G.B., McPherson, S.A., Wyman, J., Love, S., Reed, G. and
Biever, D. (1993) Genetically improved potatoes: protection
from damage by Colorado potato beetles. Plant Mol. Biol. 22,
313–321.
Porcar, M. and Jua´rez-Pe´rez, V. (2003) PCR-based identification of
Bacillus thuringiensis. FEMS Microbiol. Rev. 26, 419–432.
Pray, C.E., Huang, J., Hu, R. and Rozelle, S. (2002) Five years of
Bt cotton in China - the benefits continue. Plant J. 31, 423–
430.
Rajamohan, F., Alzate, O., Cotrill, J.A., Curtiss, A. and Dean, D.H.
(2006) Protein engineering of Bacillus thuringiensis delta-
endotoxin: mutations at domain II of CryIAb enhance receptor
affinity and toxicity toward gypsy moth larvae. Proc. Natl Acad.
Sci. U S A, 93, 14338–14343.
Reed, G.L., Jensen, A.S., Riebe, J.F., Head, G. and Duan, J.J.
(2001) Transgenetic Bt potato and conventional insecticides for
Colorado potato beetle management: comparative efficacy and
non-target impacts. Entomologia Experimentalis et Applicata,
100, 89–100.
Rodrı´guez-Almaza´n, C., Zavala, L.E., Mun˜oz-Garay, C., Jime´nez-
Jua´rez, N., Pacheco, S., Masson, L., Sobero´n, M. and Bravo, A.
(2009) Dominant negative mutants of Bacillus thuringiensis
Cry1Ab toxin function as anti-toxins: demonstration of the role
of oligomerization in toxicity. PLoS ONE, 4, e5545.
Sanchis, V. and Bourguet, D. (2008) Bacillus thuringiensis:
applications in agriculture and insect resistance management. A
review. Agron. Sustain. Dev. 28, 11–20.
Shelton, A.M., Zhao, J.Z. and Roush, R.T. (2002) Economic,
ecological, food safety, and social consequences of the
deployment of Bt transgenic plants. Ann. Rev. Entomol. 47,
845–881.
Siegel, J.P. (2000) Bacteria. In Field Manual of Techniques in
Invertebrate Pathology (Lacey, L.L. and Kaya, H.K. eds), pp.
209–230. Dordrecht, Netherlands: Kluwer Scientific Publishers.
Siegel, J.P. (2001) The mammalian safety of Bacillus thuringiensis-
based insecticides. J. Invertebr. Pathol. 77, 13–21.
Sobero´n, M., Gill, S.S. and Bravo, A. (2009) Signaling versus
punching hole: how do Bacillus thuringiensis toxins kill insect
midgut cells? Cell. Mol. Life Sci. 66, 1337–1349.
Subramanian, A. and Qaim, M. (2010) The Impact of Bt cotton
on poor households in rural India. J. Dev. Sci. 46, 295–311.
Sun, Y. and Park, H.W. (2010) Proteomic analysis of the crystal
and spore mixture from Bacillus thuringiensis strains to search
for novel mosquitocidal proteins. NCBI database, http://
www.ncbi.nlm.nih.gov/protein/292398077.
Tabashnik, B.E., Dennehy, T.J. and Carrie`re, Y. (2005) Delayed
resistance to transgenic cotton in pink bollworm. Proc. Natl
Acad. Sci. U S A, 102, 15389–15393.
Tabashnik, B.E., Gassmann, A.J., Crowder, D.W. and Carrie´re, Y.
(2008) Insect resistance to Bt crops: evidence versus theory.
Nature Biotechnol. 26, 199–202.
Vaeck, M., Reynaerts, A., Ho¨fte, H., Jansens, S., De Beuckeleer,
M., Dean, C., Zabeau, M., Van Montagu, M. and Leemans, J.
(1987) Transgenic plants protected from insect attack. Nature,
328, 33–37.
Walters, F.S., deFontes, C.M., Hart, H., Warren, G.W. and Chen,
J.S. (2010) Lepidopteran-active variable-region sequence imparts
coleopteran activity in eCry3.1Ab, an engineered Bacillus
thuringiensis hybrid insecticidal protein. Appl. Environ.
Microbiol. 76, 3082–3088.
Wang, G., Zhang, J., Song, F., Gu, A., Uwais, A., Shao, T. and
Huang, D. (2008) Recombinant Bacillus thuringiensis strain
shows high insecticidal activity against Plutella xylostella and
Leptinotarsa decemlineata without affecting nontarget species
in the field. J. Appl. Microbiol. 105, 1536–1543.
Zeilinger, A.R., Andow, D.A., Zwahlen, C. and Stotzky, G. (2010)
Earthworm populations in a northern U.S. Cornbelt soil are not
affected by long-term cultivation of Bt maize expressing Cry1Ab
and Cry3Bb1 proteins. Soil Biol. Biochem. 42, 1284–1292.
Zhang, X., Candas, M., Griko, N.B., Taissing, R. and Bulla Jr, L.A.
(2006) A mechanism of cell death involving an adenylyl
cyclase ⁄ PKA signaling pathway is induced by the Cry1Ab toxin
of Bacillus thuringiensis. Proc. Natl Acad. Sci. U S A, 103,
9897–9902.
Zhang, L., Huang, E., Lin, J., Gelbic, I., Zhang, Q., Guan, Y.,
Huang, T. and Guan, X. (2010) A novel mosquitocidal Bacillus
thuringiensis strain LLP29 isolated from the phylloplane of
Magnolia denudata. Microbiol. Res. 165, 133–141.
ª 2011 The Authors
Plant Biotechnology Journal ª 2011 Society for Experimental Biology, Association of Applied Biologists and Blackwell Publishing Ltd, Plant Biotechnology Journal, 9, 283–300
A century of Bacillus thuringiensis 299
Zhao, J., Jin, L., Yang, Y. and Wu, Y. (2010) Diverse cadherin
mutations conferring resistance to Bacillus thuringiensis toxin
Cry1Ac in Helicoverpa armigera. Insect Biochem. Mol. Biol. 40,
113–118.
Supporting information
Additional Supporting information may be found in the
online version of this article:
Table S1 The distribution of Bt patents in 2010 (Updated
from Krattiger (1996) with data from EU and US patent
databases).
Table S2 Companies engaged in the commercial develop-
ment of Bt crops.
Table S3 Commercial status of Bt crops. Data from Cen-
ter for Environmental Risk Assessment (CERA) GM crop
database.
Please note: Wiley-Blackwell are not responsible for the
content or functionality of any supporting materials sup-
plied by the authors. Any queries (other than missing
material) should be directed to the corresponding author
for the article.
ª 2011 The Authors
Plant Biotechnology Journal ª 2011 Society for Experimental Biology, Association of Applied Biologists and Blackwell Publishing Ltd, Plant Biotechnology Journal, 9, 283–300
Georgina Sanahuja et al.300
